Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
802 participants
INTERVENTIONAL
2005-03-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home-Based Program to Treat High Blood Pressure in African Americans
NCT00139490
Controlling Hypertension in Diabetes- Feasibility Study
NCT01145742
Blood Pressure Control in African Americans
NCT00233220
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT05293756
Achieving Blood Pressure Control Together Study
NCT01902719
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ultimate goal of this study is to reduce the incidence of HTN-related CVD among these populations thereby reducing cardiovascular health disparities. Specific aims of the study are to:
1. test whether receiving money each time the patient fills a prescription for medications improves BP control by a clinically significant amount.
H1: Reimbursing patients for filling prescriptions will significantly improve BP control.
2. test whether a computer-based behavioral intervention improves BP control by a clinically significant amount.
H2: A computer-based behavioral intervention will significantly improve BP control.
3. test whether the two interventions are more effective in improving BP control than either alone.
H3: The effect of improving BP control of administering both interventions together will be greater than the sum of the individual effects of each intervention alone.
4. examine the relative cost effectiveness of reimbursement for filling prescriptions, a computer-based behavioral intervention, and the combination of the two.
H4: Both interventions will be cost-effective relative to other commonly-covered services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Control
Control
No intervention
2
Reduction of financial barrier
Reduction in financial barrier
Copay only
3
Computer Intervention
Computer
Computer intervention only
4
Reduction of financial barrier and Computer Intervention
Computer intervention & reduction of financial barrier
computer intervention \& copay
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer
Computer intervention only
Reduction in financial barrier
Copay only
Computer intervention & reduction of financial barrier
computer intervention \& copay
Control
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Have a diagnosis of:
* Atrial fibrillation;
* Metastatic cancer;
* End stage renal disease (ESRD) with dialysis;
* Dementia;
* New York Heart Association (NYHA) class IV congestive heart failure (CHF);
* Blind or deaf;
* Other reason for life expectancy of less than 1 year.
* Are currently participating in another experimental study
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pennsylvania Department of Health
OTHER_GOV
Dickinson College
OTHER
Pfizer
INDUSTRY
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stephen E. Kimmel
Stephen E. Kimmel, M.D., M.S.C.E,
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen E. Kimmel, MD, MSCE
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PinnacleHealth Adult Outpatient Clinics
Harrisburg, Pennsylvania, United States
Veterans Administration Medical Center
Philadelphia, Pennsylvania, United States
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Volpp KG, Troxel AB, Long JA, Ibrahim SA, Appleby D, Smith JO, Jaskowiak J, Helweg-Larsen M, Doshi JA, Kimmel SE. A randomized controlled trial of co-payment elimination: the CHORD trial. Am J Manag Care. 2015 Aug;21(8):e455-64.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
707850
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.